[1]
Qing Z, Kun J, Wang T, et al. Effect of the Histone Deacetylases Inhibitors on the Differentiation of Stem Cells in Bone Damage Repairing and Regeneration. Curr Stem Cell Res Ther 2020; 15(1): 24-31.
[2]
Yang X, Zheng H, Liu Y, et al. Puerarin for OVX-induced postmenopausal osteoporosis in murine model: Systematic review and meta-analysis. Curr Stem Cell Res Ther 2020; 15(1): 37-42.
[http://dx.doi.org/10.2174/1574888X14666190703143946]
[http://dx.doi.org/10.2174/1574888X14666190703143946]
[3]
Cao Y, Smith W, Yan L, et al. Overview of cellular mechanisms and signaling pathways of Piceatannol. Stem Cell Res Ther 2020; 15(1): 4-10.
[http://dx.doi.org/10.2174/1574888X14666190402100054]
[http://dx.doi.org/10.2174/1574888X14666190402100054]
[4]
Wang Y, Wang B, Yang X, et al. The study of cellular mechanism of triptolide in the treatment of cancer, bone loss and cardiovascular disease and triptolide’s toxicity. Stem Cell Res Ther 2020; 15(1): 18-23.
[http://dx.doi.org/10.2174/1574888X14666190301155810]
[http://dx.doi.org/10.2174/1574888X14666190301155810]
[5]
Zhang X, Zhang K, Wang Y, et al. Biological effects study of Myricitrin and relevant molecular mechanisms. Stem Cell Res Ther 2020; 15(1): 11-7.
[http://dx.doi.org/10.2174/1574888X14666181126103338]
[http://dx.doi.org/10.2174/1574888X14666181126103338]